Prelude Capital Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-13,911
Closed -$88.2K – 1361
2026
Q2
$88.2K Buy
+13,911
New +$68.2K 0.01% 1128
2025
Q4
– Sell
-10,109
Closed -$70.4K – 1288
2025
Q3
$70.4K Buy
+10,109
New +$71.3K 0.01% 1085
2025
Q2
– Sell
-50,226
Closed -$321K – 1012
2025
Q1
$321K Buy
50,226
+31,021
+162% +$299K 0.02% 675
2024
Q4
$228K Buy
+19,205
New +$327K 0.01% 931
2023
Q4
– Sell
-20,513
Closed -$176K – 1130
2023
Q3
$176K Buy
+20,513
New +$146K 0.01% 929
2023
Q2
– Sell
-33,155
Closed -$247K – 1121
2023
Q1
$247K Buy
33,155
+5,700
+21% +$56.7K 0.01% 750
2022
Q4
$324K Buy
+27,455
New +$314K 0.02% 767
2020
Q4
– Sell
-500
Closed -$5K – 1288
2020
Q3
$5K Buy
+500
New +$3.96K ﹤0.01% 1548
2020
Q1
– Sell
-7,229
Closed -$56K – 1427
2019
Q4
$56K Buy
7,229
+4,232
+141% +$29.2K ﹤0.01% 1295
2019
Q3
$18K Buy
+2,997
New +$19.1K ﹤0.01% 1406

Other funds holding ASPN

Prelude Capital Management's ASPN Position: Q3 2026 in Review

Prelude Capital Management sold out of Aspen Aerogels (ASPN) in Q3 2026, closing a stake of 13,911 shares — an estimated $88.2K sold.

Prelude Capital Management first reported a position in ASPN in Q3 2019 and held it in 10 quarters. The position peaked at $324K in Q4 2022. 186 funds tracked by Wall St. Rank hold ASPN as of Q3 2026.

  • Prelude Capital Management reported no remaining Aspen Aerogels position as of Q3 2026 after selling out during the quarter.
  • Prelude Capital Management sold 13,911 Aspen Aerogels shares in Q3 2026, an estimated $88.2K.
  • Prelude Capital Management first reported a position in Aspen Aerogels in Q3 2019 and held it in 10 quarters.
  • Prelude Capital Management's Aspen Aerogels position peaked at $324K in Q4 2022.
  • 186 funds tracked by Wall St. Rank held Aspen Aerogels as of Q3 2026.

Based on Prelude Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.